These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 16494472)

  • 1. Chemoenzymatic syntheses of iGb3 and Gb3.
    Yao Q; Song J; Xia C; Zhang W; Wang PG
    Org Lett; 2006 Mar; 8(5):911-4. PubMed ID: 16494472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the ceramide moiety of isoglobotrihexosylceramide on its agonist activity in stimulation of invariant natural killer T cells.
    Xia C; Schümann J; Emmanuel R; Zhang Y; Chen W; Zhang W; De Libero G; Wang PG
    J Med Chem; 2007 Jul; 50(15):3489-96. PubMed ID: 17608465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thio-isoglobotrihexosylceramide, an agonist for activating invariant natural killer T cells.
    Xia C; Zhou D; Liu C; Lou Y; Yao Q; Zhang W; Wang PG
    Org Lett; 2006 Nov; 8(24):5493-6. PubMed ID: 17107055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analogues.
    Chen W; Xia C; Wang J; Thapa P; Li Y; Talukdar A; Nadas J; Zhang W; Zhou D; Wang PG
    J Org Chem; 2007 Dec; 72(26):9914-23. PubMed ID: 18020363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3).
    Xia C; Yao Q; Schümann J; Rossy E; Chen W; Zhu L; Zhang W; De Libero G; Wang PG
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2195-9. PubMed ID: 16458002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic synthesis of Gb3 and iGb3 ceramides.
    Adlercreutz D; Weadge JT; Petersen BO; Duus JØ; Dovichi NJ; Palcic MM
    Carbohydr Res; 2010 Jul; 345(10):1384-8. PubMed ID: 20206917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A divergent approach to the synthesis of iGb3 sugar and lipid analogues via a lactosyl 2-azido-sphingosine intermediate.
    Cheng JM; Dangerfield EM; Timmer MS; Stocker BL
    Org Biomol Chem; 2014 May; 12(17):2729-36. PubMed ID: 24652424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha anomers of iGb3 and Gb3 stimulate cytokine production by natural killer T cells.
    Yin N; Long X; Goff RD; Zhou D; Cantu C; Mattner J; Mezard PS; Teyton L; Bendelac A; Savage PB
    ACS Chem Biol; 2009 Mar; 4(3):199-208. PubMed ID: 19175331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive quantitation of isoglobotriaosylceramide in the presence of isobaric components using electrospray ionization-ion trap mass spectrometry.
    Li Y; Zhou D; Xia C; Wang PG; Levery SB
    Glycobiology; 2008 Feb; 18(2):166-76. PubMed ID: 18048405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical modification of iGb3 increases IFN-gamma production by hepatic NKT cells.
    Shang P; Zhang C; Xia C; Chen W; Han Q; Wang PG; Zhang J; Tian Z
    Int Immunopharmacol; 2008 May; 8(5):645-53. PubMed ID: 18387506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glycosphingolipids Gb3 and iGb3. In vivo roles in hemolytic-uremic syndrome and iNKT cell function].
    Porubsky S; Luckow B; Bonrouhi M; Speak A; Cerundolo V; Platt F; Gröne HJ
    Pathologe; 2008 Nov; 29 Suppl 2():297-302. PubMed ID: 18810447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation.
    Christiansen D; Milland J; Mouhtouris E; Vaughan H; Pellicci DG; McConville MJ; Godfrey DI; Sandrin MS
    PLoS Biol; 2008 Jul; 6(7):e172. PubMed ID: 18630988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large scale enzymatic synthesis of oligosaccharides and a novel purification process.
    Zhou G; Liu X; Su D; Li L; Xiao M; Wang PG
    Bioorg Med Chem Lett; 2011 Jan; 21(1):311-4. PubMed ID: 21130648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lipid chain lengths in alpha-galactosylceramides on cytokine release by natural killer T cells.
    Goff RD; Gao Y; Mattner J; Zhou D; Yin N; Cantu C; Teyton L; Bendelac A; Savage PB
    J Am Chem Soc; 2004 Oct; 126(42):13602-3. PubMed ID: 15493902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
    Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
    J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis of the preferential binding for globo-series glycosphingolipids displayed by Pseudomonas aeruginosa lectin I.
    Blanchard B; Nurisso A; Hollville E; Tétaud C; Wiels J; Pokorná M; Wimmerová M; Varrot A; Imberty A
    J Mol Biol; 2008 Nov; 383(4):837-53. PubMed ID: 18762193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells.
    Liu Y; Goff RD; Zhou D; Mattner J; Sullivan BA; Khurana A; Cantu C; Ravkov EV; Ibegbu CC; Altman JD; Teyton L; Bendelac A; Savage PB
    J Immunol Methods; 2006 May; 312(1-2):34-9. PubMed ID: 16647712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RCAI-8, 9, 18, 19, and 49-52, conformationally restricted analogues of KRN7000 with an azetidine or a pyrrolidine ring: Their synthesis and bioactivity for mouse natural killer T cells to produce cytokines.
    Fuhshuku K; Hongo N; Tashiro T; Masuda Y; Nakagawa R; Seino K; Taniguchi M; Mori K
    Bioorg Med Chem; 2008 Jan; 16(2):950-64. PubMed ID: 17950609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Globoside as a membrane receptor: a consideration of oligosaccharide communication with the hydrophobic domain.
    Jones DH; Lingwood CA; Barber KR; Grant CW
    Biochemistry; 1997 Jul; 36(28):8539-47. PubMed ID: 9214299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vivo evaluation of 4-deoxy-4,4-difluoro-KRN7000.
    Leung L; Tomassi C; Van Beneden K; Decruy T; Elewaut D; Elliott T; Al-Shamkhani A; Ottensmeier C; Van Calenbergh S; Werner J; Williams T; Linclau B
    Org Lett; 2008 Oct; 10(20):4433-6. PubMed ID: 18798635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.